SCHEMBL4558340

SCHEMBL4558340

COc1cc2c(Nc3ccc(CCc4ccccc4)cc3)ccnc2cc1OCCCN1CCOCC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 12/20 0.71
SRC P12931 5/20 0.59
KDR P35968 3/20 0.58
EGFR P00533 2/20 0.58
MET P08581 2/20 0.58
RAF1 P04049 1/20 0.58
MAPK3 P27361 1/20 0.58
MAPK1 P28482 1/20 0.58
AURKA O14965 1/20 0.58
ROCK2 O75116 1/20 0.58
ALDH1A1 P00352 1/20 0.58
LCK P06239 1/20 0.58
FYN P06241 1/20 0.58
RET P07949 1/20 0.58
MAPT P10636 1/20 0.58
PDGFRA P16234 1/20 0.58
LTK P29376 1/20 0.58
TTK P33981 1/20 0.58
MAP2K2 P36507 1/20 0.58
BTK Q06187 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557892 0.88 MAP2K1 (0.73) MAP2K1SRCKDREGFRMET
SCHEMBL4557789 0.86 MAP2K1 (0.73) MAP2K1SRCKDREGFRMET
SCHEMBL4445567 0.85 SRC (0.62) MAP2K1SRCKDREGFRMET
SCHEMBL4447904 0.85 MAP2K1 (0.72) MAP2K1SRCKDREGFRMET
SCHEMBL18828353 0.85 SRC (0.57) MAP2K1SRCKDREGFRMET
SCHEMBL27731209 0.84 KDR (0.62) SRCKDREGFRMETLCK
SCHEMBL4447835 0.83 MAP2K1 (0.64) MAP2K1SRCKDRMETRAF1
SCHEMBL4457381 0.83 MAP2K1 (1.00) MAP2K1EGFRRAF1MAPK3MAPK1
SCHEMBL12308286 0.82 EGFR (0.77) SRCKDREGFRMETLCK
SCHEMBL3911219 0.79 FLT3 (0.74) MAP2K1SRCKDREGFRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009151910-A2 COMBINATION PRODUCT OF RECEPTOR TYROSINE KINASE INHIBITOR AND FATTY ACID SYNTHASE INHIBITOR FOR TREATING CANCER WYETH (US) 2009-12-17 WO disclosed